Disruption of Caveolae Blocks Ischemic Preconditioning-Mediated S-Nitrosylation of Mitochondrial Proteins
- 1 January 2012
- journal article
- research article
- Published by Mary Ann Liebert Inc in Antioxidants and Redox Signaling
- Vol. 16 (1), 45-56
- https://doi.org/10.1089/ars.2010.3844
Abstract
Aims: Nitric oxide (NO) and protein S-nitrosylation (SNO) play important roles in ischemic preconditioning (IPC)-induced cardioprotection. Mitochondria are key regulators of preconditioning, and most proteins showing an increase in SNO with IPC are mitochondrial. The aim of this study was to address how IPC transduces NO/SNO signaling to mitochondria in the heart. Results: In this study using Langendorff perfused mouse hearts, we found that IPC-induced cardioprotection was blocked by treatment with either N-nitro-L-arginine methyl ester (L-NAME, a constitutive NO synthase inhibitor), ascorbic acid (a reducing agent to decompose SNO), or methyl-β-cyclodextrin (MβCD, a cholesterol sequestering agent to disrupt caveolae). IPC not only activated AKT/eNOS signaling but also led to translocation of eNOS to mitochondria. MβCD treatment disrupted caveolar structure, leading to dissociation of eNOS from caveolin-3 and blockade of IPC-induced activation of the AKT/eNOS signaling pathway. A significant increase in mitochondrial SNO was found in IPC hearts compared to perfusion control, and the disruption of caveolae by MβCD treatment not only abolished IPC-induced cardioprotection, but also blocked the IPC-induced increase in SNO. Innovation: These results provide mechanistic insight into how caveolae/eNOS/NO/SNO signaling mediates cardioprotection induced by IPC. Conclusion: Altogether these results suggest that caveolae transduce eNOS/NO/SNO cardioprotective signaling in the heart. Antioxid. Redox Signal. 16, 45–56.Keywords
This publication has 43 references indexed in Scilit:
- eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sexAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Cardioprotection leads to novel changes in the mitochondrial proteomeAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Internalization of eNOS and NO delivery to subcellular targets determine agonist-induced hyperpermeabilityProceedings of the National Academy of Sciences of the United States of America, 2009
- Endogenous S -nitrosothiols protect against myocardial injuryProceedings of the National Academy of Sciences of the United States of America, 2009
- Endothelial nitric oxide synthase is not necessary for the early phase of ischemic preconditioning in the mouseJournal of Molecular and Cellular Cardiology, 2008
- Caveolae as Organizers of Pharmacologically Relevant Signal Transduction MoleculesAnnual Review of Pharmacology and Toxicology, 2008
- Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injuryJournal of Molecular and Cellular Cardiology, 2008
- The multiple faces of caveolaeNature Reviews Molecular Cell Biology, 2007
- Nitric oxide synthase generates nitric oxide locally to regulate compartmentalized protein S-nitrosylation and protein traffickingProceedings of the National Academy of Sciences of the United States of America, 2006
- Molecular Cloning of Caveolin-3, a Novel Member of the Caveolin Gene Family Expressed Predominantly in MuscleJournal of Biological Chemistry, 1996